NYSE: XHRXenia Hotels & Resorts Inc Stock
$14.27+0.33 (+2.37%)
Updated Aug 27, 2025
XHR Price
$14.27
Fair Value Price
N/A
Market Cap
$1.37B
52 Week Low
$8.55
52 Week High
$16.50
P/E
22.65x
P/B
1.12x
P/S
1.14x
PEG
0.42x
Dividend Yield
2.8%
Revenue
$1.08B
Earnings
$63.01M
Gross Margin
30.4%
Operating Margin
13.78%
Profit Margin
5.9%
Debt to Equity
1.33
Operating Cash Flow
$173M
Beta
1.32
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
XHR Overview
Xenia Hotels & Resorts Incorporated is a Real Estate Investment Trust (REIT) that invests in luxury and upper upscale hotels and resorts. It focuese on the top lodging markets and leisure destinations in the U.S. The company owns 37 hotels (10,749 rooms) across 16 states. Xenia's hotels are operated by well-known names including Marriott, Hyatt, Kimpton, Fairmont, Loews,, and Hilton. The company was founded in 2014 and is headquartered in Orlando,FL.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine XHR's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Hotel & Motel REIT
Industry Rating
F
XHR
Ranked#1 of 14
Ranked#1 of 14
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $2.73 | C | |
| $17.37 | C | |
| $8.59 | C |
Be the first to know about important XHR news, forecast changes, insider trades & much more!
XHR News
Overview
Due Diligence Score
–
Industry Average (21)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how XHR scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
XHR ($14.27) is trading below its intrinsic value of $16.00, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
XHR is good value based on its earnings relative to its share price (22.65x), compared to the US market average (35.44x)
P/E vs Market Valuation
XHR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more XHR due diligence checks available for Premium users.
Valuation
XHR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
22.65x
Industry
39.13x
Market
35.44x
XHR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
XHR is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
XHR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.12x
Industry
1.27x
XHR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
XHR price to earnings growth (PEG)
For valuing profitable companies with growth potential
XHR is good value based... subscribe to Premium to read more.
PEG Value Valuation
XHR's financial health
Profit margin
Revenue
$287.6M
Net Income
$55.2M
Profit Margin
19.2%
XHR's Earnings (EBIT) of $148.20M... subscribe to Premium to read more.
Interest Coverage Financials
XHR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.9B
Liabilities
$1.6B
Debt to equity
1.33
XHR's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
XHR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$36.3M
Investing
$83.7M
Financing
-$51.1M
XHR's operating cash flow ($172.86M)... subscribe to Premium to read more.
Debt Coverage Financials
XHR vs Hotel & Motel REIT Stocks
Xenia Hotels & Resorts Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.